Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TCM Biotech InternationalTPE:4169 -2.48%52 Dividend Yield % is 0.20% as of Aug. 10, 2026, which is 29% below its 10-year median of 0.28. GuruFocus rates TPE:4169 with a GF Score™ of 52/100 and a GF Value™ of NT$42.31 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 150 Biotechnology companies, TCM Biotech International ranks worse than 92.67% on this metric.
During the past 12 months, TCM Biotech International's average Dividends Per Share Growth Rate was 22.80% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of TCM Biotech International was 172.40% per year. The lowest was -55.00% per year. And the median was -3.40% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
TCM Biotech International (TPE:4169) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:4169 vs VRTX, REGN, RVMD: Dividend Yield % Comparison
For the Biotechnology subindustry, TCM Biotech International's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TCM Biotech International Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, TCM Biotech International's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where TCM Biotech International's Dividend Yield % falls into.
TCM Biotech International Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
TCM Biotech International Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
TWD 0.319991
2026-07-20
2026-07-21
2026-08-14
Cash Dividend
annually
TWD:TWD 1.000000
TWD 0.350000
2025-08-28
2025-08-29
2025-09-26
Cash Dividend
annually
TWD:TWD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TCM Biotech International (TPE:4169) has a Dividend Yield % of 0.20% as of Aug. 10, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on TCM Biotech International and its competitors. This is 29% below median its historical median of 0.28. Over the past decade, TCM Biotech International's Dividend Yield % has ranged from 0.13 to 0.57. According to the industry distribution chart, TCM Biotech International ranks #139 out of 150 companies in the Biotechnology industry, placing it in the top 92.7%.
Is TCM Biotech International's Dividend Yield % too high?
TCM Biotech International's current Dividend Yield % of 0.20% is 29% below median its 10-year median of 0.28. Over the past 10 years, this metric has ranged from a low of 0.13 to a high of 0.57. The Biotechnology industry median Dividend Yield % is 1.27. TCM Biotech International's value of 0.20% is 84.2% below this industry median. Based on the distribution chart, TCM Biotech International ranks #139 out of 150 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, TCM Biotech International has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TCM Biotech International's Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, TCM Biotech International ranks #139 out of 150 companies for Dividend Yield %. This places TCM Biotech International in the lower half of its industry. The industry median Dividend Yield % is 1.27. TCM Biotech International's value of 0.20% is 84.2% below this benchmark. Historically, TCM Biotech International's own Dividend Yield % has ranged from 0.13 to 0.57 over the past decade. While the company's 10-year median is 0.28 vs. the industry median of 1.27, TCM Biotech International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.27, based on 150 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TCM Biotech International's current Dividend Yield % of 0.20% is 84.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on TCM Biotech International and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TCM Biotech International's current Dividend Yield % is 0.20%, which is 29% below median its own 10-year median of 0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TCM Biotech International stock overvalued right now?
Based on GuruFocus' analysis, TCM Biotech International (TPE:4169) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$42.31, compared to a current price of NT$157.00 — trading 271.1% above its estimated fair value. The current Dividend Yield % is 0.20%, which is 29% below median its 10-year median of 0.28 and 84.2% below the Biotechnology industry median of 1.27. TCM Biotech International's overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For TCM Biotech International (TPE:4169), the current Dividend Yield % is 0.20% as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TCM Biotech International (TPE:4169) Overvalued in 2026?
Based on GuruFocus' analysis, TCM Biotech International stock appears to be overvalued.
The current stock price of NT$157.00 is trading 271.1% above its estimated GF Value™ of NT$42.31.
GuruFocus considers TCM Biotech International to be Significantly Overvalued.
Key valuation signals for TPE:4169:
Dividend Yield %: 0.20% (29% below median its 10-year median of 0.28)
GF Value™: NT$42.31 vs. price of NT$157.00 (271.1% above fair value)
Industry Position: 84.2% below the Biotechnology median (#139 of 150)
No single metric tells the full story. See the TPE:4169 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TCM Biotech International Corp is a Taiwan based biotechnology company. It is engaged in research and development of new biotech drugs, development of microbial strain cultivation and fermentation technology, biotechnology services, wholesale of medical equipment, and sales of functional foods. Its products includes medical equipment, medical testing platform, medical drugs, and others. The Group has two reportable segments: Segment A and Segment B. Segment A is the functional foods segment, while Segment B is the pharmaceuticals segment. It derives maximum revenue from pharmaceuticals segment. Geographically, the company operates in Taiwan and Other countries, of which it generates maximum revenue from Taiwan.
52GF Score
Get the complete analysis for TPE:4169
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4169 has been successfully added to your 
